APA (7th ed.) Citation

Zhang, Y., Patel, R. P., Kim, K. H., Cho, H., Jo, J., Jeong, S. H., . . . Ghilardi, G. (2023). Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: A first-in-human study. Molecular Cancer, 22(1), 1. https://doi.org/10.1186/s12943-023-01886-9

Chicago Style (17th ed.) Citation

Zhang, Yunlin, et al. "Safety and Efficacy of a Novel Anti-CD19 Chimeric Antigen Receptor T Cell Product Targeting a Membrane-proximal Domain of CD19 with Fast on- and Off-rates Against Non-Hodgkin Lymphoma: A First-in-human Study." Molecular Cancer 22, no. 1 (2023): 1. https://doi.org/10.1186/s12943-023-01886-9.

MLA (9th ed.) Citation

Zhang, Yunlin, et al. "Safety and Efficacy of a Novel Anti-CD19 Chimeric Antigen Receptor T Cell Product Targeting a Membrane-proximal Domain of CD19 with Fast on- and Off-rates Against Non-Hodgkin Lymphoma: A First-in-human Study." Molecular Cancer, vol. 22, no. 1, 2023, p. 1, https://doi.org/10.1186/s12943-023-01886-9.